Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AURKA | O14965 | 1/20 | 0.37 |
| ▸ | TPX2 | Q9ULW0 | 1/20 | 0.37 |
| ▸ | GPR3 | P46089 | 1/20 | 0.37 |
| ▸ | KIF11 | P52732 | 1/20 | 0.37 |
| ▸ | MMP12 | P39900 | 1/20 | 0.36 |
| ▸ | CNR1 | P21554 | 1/20 | 0.36 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | PPARD | Q03181 | 1/20 | 0.35 |
| ▸ | BCHE | P06276 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.35 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.35 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.35 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.34 |
| ▸ | DHODH | Q02127 | 1/20 | 0.34 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.34 |
| ▸ | SCN5A | Q14524 | 2/20 | 0.34 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.34 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18735549 | 0.89 | PDE2A (0.34) | GPR3TRPV1KDM4EPPARDSCN10A | |
| SCHEMBL18735550 | 0.87 | GPR3 (0.42) | GPR3CNR1TRPV1AKR1C2PTGDR2 | |
| SCHEMBL18735552 | 0.86 | CYP11B1 (0.32) | KIF11PPARD | |
| SCHEMBL15745093 | 0.83 | PPARD (0.32) | AURKATPX2GPR3KIF11MMP12 | |
| SCHEMBL10018707 | 0.82 | ACHE (0.38) | KIF11PPARDBCHEACHE | |
| SCHEMBL7729109 | 0.82 | ACHE (0.45) | GPR3KIF11TRPV1KDM4EBCHE | |
| SCHEMBL12152581 | 0.82 | ACHE (0.38) | KIF11PPARDBCHEACHE | |
| SCHEMBL19415114 | 0.81 | FFAR4 (0.44) | GPR3KIF11SCN10ASCN5ANISCH | |
| SCHEMBL12889548 | 0.79 | FFAR4 (0.39) | GPR3KIF11BCHEACHESCN10A | |
| SCHEMBL4431222 | 0.79 | NFE2L2 (0.38) | GPR3TRPV1KDM4EPPARDFFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9803140-B2 | Liquid crystal compound and liquid crystal composition | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIALS CO., LTD. (CN) | 2017-10-31 | — | — | US | disclosed |
| US-20170101581-A1 | LIQUID CRYSTAL COMPOUND AND LIQUID CRYSTAL COMPOSITION | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIALS CO., LTD. (CN) | 2017-04-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170101581-A1 | LIQUID CRYSTAL COMPOUND AND LIQUID CRYSTAL COMPOSITION | LBR, CTNND1, CCNT1 | AURKA 1616/4885TPX2 3202/4885GPR3 3536/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.